Analysts: Johnson & Johnson’s Outlook Is Positive and 3 Other Research Notes to Browse
Johnson & Johnson (NYSE:JNJ): Bernstein expects Johnson & Johnson to report higher-than-expected third-quarter earnings per share, since the firm predicts that the company’s over-the-counter sales grew 8 percent during the quarter. Bernstein is upbeat on the outlook for Johnson & Johnson’s pharmaceutical sales and keeps a $97 price target and Outperform rating on the shares.
Discover (NYSE:DFS): Citigroup upgraded Discover to Buy from Neutral, citing a more attractive risk/reward outlook following the recent pullback in shares; the firm has raised its price target for Discover shares to $56 from $53.
Sony (NYSE:SNE): Citigroup downgraded Sony to Neutral from Buy based on concerns that earnings in Sony’s TV, PC, and camera businesses could fall short of expectations.
Netflix (NASDAQ:NFLX): Needham initiated Netflix with a Buy and a $425 price target for the shares. The firm believes Netflix is the best way to play global broadband growth and that international markets will visibly drive growth for the next three to five years.